Content related to Basic Research Led to First FDA-Approved Immunotherapy for Pediatric Cancer

A recent study found that the growth factor G-CSF, used in high-risk neuroblastoma treatment, leads to increased tumor growth and metastasis. Investigators think the benefits still outweigh the risks.

What are the advantages of immunotherapy compared to traditional cancer treatments, such as chemotherapy and radiation?

Investigators at The Saban Research Institute of Children’s Hospital Los Angeles have developed and tested a new biomarker assay for quantifying disease and detecting the presence of neuroblastoma

A CHLA oncologist led a pivotal clinical trial leading to the approval of the first drug to prevent cisplatin hearing loss in children.

Children’s Hospital Los Angeles is the only hospital in Southern California where patients can receive MIBG therapy, a specialized targeted radiation therapy for neuroblastoma.

Ella and her family moved from the East Coast to Southern California in search of the best treatment for high-risk neuroblastoma—and found it at Children’s Hospital Los Angeles.

Katie Hawley was a rising young soccer star when cancer hit at age 9. Now she balances a desire to be a “typical” teenager with the challenges of a life-threatening disease. At 18, Katie Hawley is

Meet Richard. He’s in fifth grade, loves his teacher, enjoys running, swimming and drawing, and has an ear-to-ear smile that makes him friends wherever he goes. And he’s gone a lot of places lately